共 50 条
Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners
被引:15
|作者:
Cuenca-Barrales, Carlos
[1
,2
]
Montero-Vilchez, Trinidad
[1
,2
]
Krajewski, Piotr K.
[3
]
Szepietowski, Jacek C.
[3
]
Matusiak, Lukasz
[3
]
Arias-Santiago, Salvador
[1
,2
,4
]
Molina-Leyva, Alejandro
[1
,2
]
机构:
[1] Hosp Univ Virgen Nieves, Dermatol Dept, Hidradenitis Suppurat Clin, Granada 18014, Spain
[2] Inst Invest Biosanit ibs, TECe19 Dermatol Clin & Traslac Invest Grp, GRANADA, Granada 18012, Spain
[3] Wroclaw Med Univ, Dept Dermatol, Venereol & Allergol, PL-50368 Wroclaw, Poland
[4] Univ Granada, Sch Med, Dept Dermatol, Granada 18016, Spain
关键词:
hidradenitis suppurativa;
quality of life;
sexual dysfunction;
erectile dysfunction;
sexual partners;
FAMILY-MEMBERS;
INDEX;
MULTICENTER;
IMPAIRMENT;
VALIDATION;
DISEASE;
VERSION;
IMPACT;
D O I:
10.3390/ijerph20010389
中图分类号:
X [环境科学、安全科学];
学科分类号:
08 ;
0830 ;
摘要:
Hidradenitis suppurativa (HS) is a chronic skin disease that profoundly affects patients' quality of life (QoL) and sexuality. Few data are available on the impact of HS on patients' partners. We aimed to explore the QoL and sexual function of patients' partners and the factors associated with their impairment and to compare the QoL and sexual function of single patients and those in a stable relationship. We conducted a cross-sectional study at Hospital Universitario Virgen de las Nieves (Granada, Spain) and at the Wroclaw Medical University (Wroclaw, Poland). Patients over the age of 16 years attending their scheduled follow-up and their partners, if any, were included. The Dermatology Life Quality Index (DLQI) and the Family Dermatology Life Quality Index (FDLQI) were used to estimate the QoL of patients and partners, respectively. The FSFI-6 was used to determine sexual dysfunction in women and the IIEF-5 for erectile dysfunction in men. Thirty-four single patients and twenty-eight patients in a stable relationship and their partners were included. Patients had a very large impact (DLQI 12.5 +/- 7.5) and their partners a moderate impact (FDLQI 10.3 +/- 7.1) in their QoL due to HS. Women with HS had a high prevalence of sexual dysfunction (13/32, 40.6%) and men of erectile dysfunction (19/30, 63.3%). Male partners also had a high prevalence of erectile dysfunction (10/17, 58.8%), while only one female partner had sexual dysfunction (1/11, 9.1%). Factors related to disease severity, intensity of symptoms and body mass index were associated with poorer QoL in partners and time of disease evolution with greater erectile dysfunction in male partners. In conclusion, HS not only profoundly affects the QoL and sexuality of patients but also of their partners. Several risk factors have been identified, which should be taken into account in the holistic approach of the disease.
引用
收藏
页数:10
相关论文